Propiedad y actividad de insiders de Biomea Fusion, Inc. (BMEA): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $1.74 |
| Capitalización | $126M |
| Bolsa | NASDAQ |
| País | US |
Operaciones Recientes de Insiders
| Fecha | Insider | Tipo | Acciones | Valor |
|---|---|---|---|---|
| 2026-06-10 | Faust Elizabeth | A-Award | 196,299 | $226K |
| 2026-06-10 | AGUIAR ERIC | A-Award | 196,299 | $226K |
| 2026-06-10 | Ray Sumita | A-Award | 196,299 | $226K |
| 2026-06-10 | Averill Julianne | A-Award | 173,711 | $200K |
| 2026-04-01 | Erdtmann Rainer M | A-Award | 452,512 | $674K |
| 2026-04-01 | Hitchcock Michael J.M. | A-Award | 667,477 | $995K |
| 2025-12-31 | Erdtmann Rainer M | |||
| 2025-12-31 | Erdtmann Rainer M | |||
| 2025-12-11 | Erdtmann Rainer M | P-Purchase | 30,000 | $43K |
| 2025-12-02 | Hitchcock Michael J.M. | P-Purchase | 100,000 | $99K |
Balance (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $239000 | $61.7M | $145.7M | $111.9M | $176.9M | $58.3M | $55.8M |
| Inversiones a Corto | 0 | 0 | $27.8M | $1.1M | 0 | 0 | 0 |
| Cuentas por Cobrar | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $265000 | $62.2M | $176.6M | $117.8M | $179.2M | $68.3M | $58.0M |
| Inmovilizado Material | 0 | $291000 | $5.7M | $8.0M | $14.9M | $10.6M | $153000 |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $265000 | $62.5M | $185.7M | $129.3M | $199.9M | $79.9M | $58.6M |
| Cuentas por Pagar | $271000 | $727000 | $1.3M | $6.8M | $6.9M | $12.9M | $3.2M |
| Deuda a Corto | 0 | $36000 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $286000 | $1.6M | $4.6M | $19.1M | $22.9M | $21.7M | $11.1M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $286000 | $57.4M | $6.9M | $20.8M | $30.7M | $28.4M | $29.0M |
| Reservas | -$2.9M | -$8.2M | -$49.7M | -$131.6M | -$248.8M | -$387.3M | -$449.0M |
| Patrimonio Neto | -$21000 | $5.2M | $178.8M | $108.5M | $169.2M | $51.6M | $29.6M |
| Deuda Total | 0 | $259000 | $2.9M | $2.3M | $10.3M | $8.8M | $1.6M |
| Deuda Neta | -$239000 | -$61.4M | -$170.7M | -$110.8M | -$166.6M | -$49.5M | -$54.2M |
| Capital Circulante | -$21000 | $60.6M | $171.9M | $98.7M | $156.3M | $46.7M | $46.9M |
Salud financiera
| Deuda / Patrimonio | 0.07 |
| Ratio corriente | 3.47 |
| Piotroski F-Score | 2 |
| Altman Z-Score | -13.01 |
Rentabilidad
| Rentabilidad sobre capital | -171.19% |
| Rentabilidad sobre capital invertido | -212.95% |
| Rentabilidad sobre activos | -88.24% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Empresas relacionadas: ADVM · ALXO · CAMP · CBUS · GUTS · IMUX · PMVP
Explorar sector: Healthcare · Biotechnology
Más secciones de BMEA: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones